Author

E. Blanc

h-index 3 View on Semantic Scholar

We have 2 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

A health-economic assessment of the impact of different RSVpreF maternal vaccine strategies to prevent RSV infections among young infants, in France: EPIPACT.

OBJECTIVES Most of the clinical and economic burden of the respiratory syncytial virus (RSV) in pediatric populations is concentrated among infants aged <1 year. Since 2024, RSVpreF vaccine is available in France for the vaccination of pregnant women between 32 and 36 weeks of gestational age, from September to January...

Y. Fahfouhi, S. Fiévez, R. Cohen et al. · Vaccine · 0 citations

Open access Jun 2026

Cost effectiveness and public health impact of PCV20 among adults in France.

PCV20 is a cost-saving alternative to the PCV13 → PPV23 sequence for at-risk adults in France and provides substantial public health gains and represents a highly cost-effective strategy relative to commonly cited French vaccine HTA benchmarks.

S. Fiévez, Mélanie Menara, E. Blanc et al. · BMC Public Health · 0 citations